Featured,Shroom News,Spotlight Stock Mydecine Innovations Unveils Four Novel Psychedelic Drugs By Dennis Mutua April 09, 2021 Biotech and life sciences company focusing on innovative solutions for treating mental illness and enhancing vitality Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) has unveiled four novel psychedelic drug candidates. Citi...
Psychedelic Stocks,Trends & Articles Dr. Thomas Laughren Joins BetterLife Pharma in the Capacity of a Regulatory Advisor By Dennis Mutua April 09, 2021 Former psychiatry division director in the Food and Drug Administration (FDA) Dr. Thomas Laughren has joined pharmaceutical company developing second generation psychedelics for neuro-psychiatric disorders BetterLife Pharma Inc. (...
Featured,Shroom News,Spotlight Stock Atai Life Sciences Acquires Majority Stake in Psyber Inc. By Dennis Mutua April 08, 2021 New York based psychedelic and mental health company Atai Life Sciences announced having acquired a majority stake in Delaware based Psyber Inc. Psyber majorly engages in developing interventions to improve various mental health d...
Psychedelic Stocks,Trends & Articles Aikido Granted Sublicense for Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients By Dennis Mutua April 08, 2021 United States based pharmaceutical development company Aikido Pharma Inc. (AIKI) has received a sublicense for using psilocybin treatment of neuro-inflated tissue in patients suffering from cancer. This sublicense is related to...
Featured,Trends & Articles California Inches Closer Towards Decriminalizing the Use of Psychedelics By Dennis Mutua April 07, 2021 Efforts to decriminalize use psychedelics substances in California have been revived once again after a major state senate committee voted in favor of a bill allowing adults across California to possess and use magic mushrooms and...
Shroom News,Spotlight Stock Entheon Unveils Psychedelics Genetic Test by its Subsidiary Halugen By Dennis Mutua April 07, 2021 Biotech company with a special focus on developing psychedelic medicines to treat addiction Entheon BioMedical Corp. (CNSX: ENBI) has unveiled a psychedelics genetic test kit fully developed by its wholly owned subsidiary HaluGen ...
Psychedelic Stocks,Shroom News MindMed Publishes New Data on MDMA Dosing By Dennis Mutua April 06, 2021 Leading clinical-stage psychedelic medicine biotech company Mind Medicine Inc. (OTCQB: MMEDF) has published a new set of data on Personalized MDMA Dosing. The study was conducted in the University Hospital Basel Liechti Lab, in ...
Featured,Spotlight Stock,Trends & Articles Australian Researchers to Find Out How Psilocybin Can be Used to Control Meth Addiction By Dennis Mutua April 06, 2021 Researchers from Sydney, Australia are embarking on a study to find out how psilocybin can be used to control addiction of methamphetamines simply known as meth. The researchers are seeking to establish if administering psilocybin...